The U.S. Food and Drug Administration (FDA) approved the first generic version of Climara Pro on Monday. It’s a skin patch ...

Postmenopausal women are at greater risk for multiple health issues, such as hip fractures and urinary tract infections (UTIs ...

Women are struggling to fill estrogen patch prescriptions as a shortage affecting nearly 20 formulations drags on. Here's why, and which alternatives to ask your doctor about.

When 56-year-old Lila Davachi began the menopause transition several years ago, she was caught off guard by the severe brain ...

Sen. Kirsten Gillibrand is calling for the FDA to answer the question of why women can't fill estrogen patch prescriptions a year into supply problems.

Doctors say increased demand has made some estrogen patch brands harder to find.

For the first time since 2014, the American College of Obstetricians and Gynecologists has updated its guidelines for the ...

Years after warnings that estrogen therapy could lead to increased cancer risk, a new study has found that it in addition to alleviating hot flashes and other symptoms of menopause, it carries little ...

In November, the FDA removed the black box labeling from estrogen-based HRT and the market pounced. “Trying to find estrogen patches right now is like a high-stakes scavenger hunt that nobody ...

A computational study finds that bisphenol PH, a BPA substitute, binds estrogen receptor alpha more strongly than estradiol ...

The Food and Drug Administration is facing mounting pressure to declare an estrogen patch shortage as some medical providers ...